ARTICLE | Company News
Isotechnika, ILJIN autoimmune, transplant news
April 2, 2012 7:00 AM UTC
Isotechnika said ILJIN's ILJIN Life Science Co. Ltd. subsidiary submitted a request for arbitration related to the biotech's January termination of a 2010 deal giving ILJIN Life Sciences rights to voclosporin in transplant and autoimmune indications in the U.S. and territories outside of Europe, Canada, Israel, South Africa, China and Taiwan. Isotechnika said the termination is "valid" (see BioCentury, Nov. 22, 2010 & Feb. 6, 2012). ...